Clinical Trial Results: Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 study evaluating several immunotherapy-based treatments and combinations in patients with urothelial carcinoma (bladder cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Urothelial Carcinoma, Bladder Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-08-03